Bernke te Winkel

Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors

Corinna Weber‐Schoendorfer, Angela Kayser, Tatjana Tissen‐Diabaté et al. · Journal of Hypertension · 2019 · 35 citations

Medicine, Maternal Health, Obstetrics +15

Pregnancy Outcome Following Maternal Exposure to Mirtazapine

Ursula Winterfeld, Gil Klinger, Alice Panchaud et al. · Journal of Clinical Psychopharmacology · 2015 · 34 citations

Medicine, Maternal Health, Obstetrics +15

Using Web-Based Questionnaires to Assess Medication Use During Pregnancy: A Validation Study in 2 Prospectively Enrolled Cohorts

Marleen M. H. J. van Gelder, Saskia Vorstenbosch, Bernke te Winkel et al. · American Journal of Epidemiology · 2017 · 30 citations · Full text

Medicine, Pharmacology, Clinical Pharmacology +9

Aim and Design of pREGnant, the Dutch Pregnancy Drug Register

Saskia Vorstenbosch, Bernke te Winkel, Marleen M. H. J. van Gelder et al. · Drug Safety · 2018 · 28 citations · Full text

Public Health, Maternal Health, Obstetrics +13

Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information Services

Jonathan L. Richardson, Sally Stephens, Laura Yates et al. · Reproductive Toxicology · 2016 · 26 citations

Medicine, Maternal Health, Obstetrics +12